Covered recipient · General Payments record
JERIEL WEITZ
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2021–2024
$2,933.72
- Reported across 137 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $626.66 | 36 |
| Education | $15.27 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $433.52 | 28 |
| Incyte Corporation | $57.82 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $30.09 | 1 |
| MERZ NORTH AMERICA, INC. | $25.10 | 1 |
| Smith & Nephew, Inc. | $24.16 | 1 |
| GENZYME CORPORATION | $22.71 | 1 |
| Kerecis Limited | $20.08 | 1 |
| PFIZER INC. | $15.27 | 1 |
| Galderma Laboratories, L.P. | $13.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.02 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323351 | CMS |
| ABBVIE INC. | $27.95 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323353 | CMS |
| ABBVIE INC. | $22.38 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323355 | CMS |
| ABBVIE INC. | $4.97 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323357 | CMS |
| ABBVIE INC. | $13.58 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323359 | CMS |
| ABBVIE INC. | $18.19 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323361 | CMS |
| ABBVIE INC. | $23.30 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323363 | CMS |
| ABBVIE INC. | $27.89 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323365 | CMS |
| ABBVIE INC. | $27.84 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323367 | CMS |
| ABBVIE INC. | $8.79 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323369 | CMS |
| ABBVIE INC. | $30.92 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323371 | CMS |
| ABBVIE INC. | $5.91 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323373 | CMS |
| ABBVIE INC. | $32.29 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323375 | CMS |
| ABBVIE INC. | $4.29 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323377 | CMS |
| ABBVIE INC. | $14.66 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323379 | CMS |
| ABBVIE INC. | $5.09 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323381 | CMS |
| ABBVIE INC. | $7.00 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323383 | CMS |
| ABBVIE INC. | $28.95 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323385 | CMS |
| ABBVIE INC. | $5.86 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323387 | CMS |
| ABBVIE INC. | $24.87 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323389 | CMS |
| ABBVIE INC. | $9.19 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323391 | CMS |
| ABBVIE INC. | $7.03 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323393 | CMS |
| ABBVIE INC. | $31.80 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323395 | CMS |
| ABBVIE INC. | $26.98 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323397 | CMS |
| ABBVIE INC. | $3.99 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323399 | CMS |
| ABBVIE INC. | $2.41 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323401 | CMS |
| ABBVIE INC. | $4.81 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323403 | CMS |
| ABBVIE INC. | $6.56 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106323405 | CMS |
| Galderma Laboratories, L.P. | $13.18 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145335059 | CMS |
| GENZYME CORPORATION | $22.71 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139889828 | CMS |
| Incyte Corporation | $29.41 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141175764 | CMS |
| Incyte Corporation | $28.41 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141176340 | CMS |
| Kerecis Limited | $20.08 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120094979 | CMS |
| MERZ NORTH AMERICA, INC. | $25.10 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146371205 | CMS |
| Novartis Pharmaceuticals Corporation | $30.09 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087375620 | CMS |
| PFIZER INC. | $15.27 | 07/16/2024 | Education | Undisputed | 01/23/2026 | 1131640890 | CMS |
| Smith+Nephew, Inc. | $24.16 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149610675 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.